DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR EC-NAPROSYN
All Clinical Trials for Ec-naprosyn
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00153660 ↗ | Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients | Unknown status | Chinese University of Hong Kong | Phase 3 | 2005-06-01 | The aim of this study is to compare a PPI (esomeprazole) plus a COX-2 inhibitor (celecoxib) with a PPI plus a nonselective NSAID (naproxen) in preventing recurrent ulcer bleeding in arthritis patients with a history of ulcer. The investigators hypothesized that among patients with a history of ulcer bleeding who receive prophylaxis with a PPI, celecoxib would be superior to naproxen for the prevention of recurrent ulcer bleeding irrespective of concomitant use of aspirin. |
| NCT00383487 ↗ | A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer | Terminated | Novacea | Phase 2 | 2005-03-01 | To determine whether, in this patient population, treatment with calcitriol and Naproxen is more effective in delaying the growth of prostate cancer than treatment with calcitriol alone as seen in historical controls. |
| NCT00383487 ↗ | A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer | Terminated | Stanford University | Phase 2 | 2005-03-01 | To determine whether, in this patient population, treatment with calcitriol and Naproxen is more effective in delaying the growth of prostate cancer than treatment with calcitriol alone as seen in historical controls. |
| NCT00527904 ↗ | A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO) | Completed | POZEN | Phase 3 | 2007-03-01 | This study uses an open-label design and will be conducted in approximately 60 sites aiming to enroll a total number of 200 subjects to ensure that at least 100 subjects will have 12 months exposure to PN400 (VIMOVO). |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Ec-naprosyn
Condition Name
Clinical Trial Locations for Ec-naprosyn
Trials by Country
Clinical Trial Progress for Ec-naprosyn
Clinical Trial Phase
Clinical Trial Sponsors for Ec-naprosyn
Sponsor Name
